AAAAAA
Results: 1-25/50
Authors:
VANANTWERP DJ
MARTIN SJ
VERMA IM
GREEN DR
Citation: Dj. Vanantwerp et al., INHIBITION OF TNF-INDUCED APOPTOSIS BY NF-KAPPA-B, Trends in cell biology, 8(3), 1998, pp. 107-111
Authors:
BLOMER U
KAFRI T
RANDOLPHMOORE L
VERMA IM
SAMII M
GAGE FH
Citation: U. Blomer et al., LENTIVIRAL TRANSFER OF BCL-XL AND HNGF PROTECTS CHOLINERGIC NEURONS FROM AXOTOMY-INDUCED CELL-DEATH IN-VIVO, European journal of neuroscience, 10, 1998, pp. 7018-7018
Authors:
VERMA IM
Citation: Im. Verma, HOT PAPERS - GENE-THERAPY - IN-VIVO GENE DELIVERY AND STABLE TRANSDUCTION OF NONDIVIDING CELLS BY A LENTIVIRAL VECTOR BY NALDINI,L., BLOMER,U., GALLAY,P., ORY,D., MULLIGAN,R., GAGE,F.H., VERMA,I.M., TRONO,D. -COMMENTS, The Scientist, 12(17), 1998, pp. 10-10
Authors:
VERMA IM
Citation: Im. Verma, LENTIVIRAL VECTORS FOR GENE-THERAPY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 21-21
Authors:
KANEGAE Y
TAVARES AT
BELMONTE JCI
VERMA IM
Citation: Y. Kanegae et al., ROLE OF REL NF-KAPPA-B TRANSCRIPTION FACTORS DURING THE OUTGROWTH OF THE VERTEBRATE LIMB/, Nature, 392(6676), 1998, pp. 611-614
Authors:
BLOMER U
KAFRI T
RANDOLPHMOORE L
VERMA IM
GAGE FH
Citation: U. Blomer et al., BCL-XL PROTECTS ADULT SEPTAL CHOLINERGIC NEURONS FROM AXOTOMIZED CELL-DEATH, Proceedings of the National Academy of Sciences of the United Statesof America, 95(5), 1998, pp. 2603-2608
Authors:
SCHWARZ EM
BADORFF C
HIURA TS
WESSELY R
BADORFF A
VERMA IM
KNOWLTON KU
Citation: Em. Schwarz et al., NF-KAPPA-B-MEDIATED INHIBITION OF APOPTOSIS IS REQUIRED FOR ENCEPHALOMYOCARDITIS VIRUS VIRULENCE - A MECHANISM OF RESISTANCE IN P50 KNOCKOUT MICE, Journal of virology, 72(7), 1998, pp. 5654-5660
Authors:
MIYOSHI H
BLOMER U
TAKAHASHI M
GAGE FH
VERMA IM
Citation: H. Miyoshi et al., DEVELOPMENT OF A SELF-INACTIVATING LENTIVIRUS VECTOR, Journal of virology, 72(10), 1998, pp. 8150-8157
Authors:
KAFRI T
BLOMER U
PETERSON DA
GAGE FH
VERMA IM
Citation: T. Kafri et al., SUSTAINED EXPRESSION OF GENES DELIVERED DIRECTLY INTO LIVER AND MUSCLE BY LENTIVIRAL VECTORS, Nature genetics, 17(3), 1997, pp. 314-317
Authors:
BLOMER U
KAFRI T
NALDINI L
VERMA IM
GAGE FH
Citation: U. Blomer et al., EFFICIENT AND SUSTAINED GENE-TRANSFER IN TERMINALLY DIFFERENTIATED CELLS WITH A LENTIVIRAL VECTOR, European journal of cancer, 33, 1997, pp. 111-111
Authors:
VERMA IM
Citation: Im. Verma, IN-VIVO GENE DELIVERY - HURDLES AND HOPES, The FASEB journal, 11(9), 1997, pp. 29-29
Authors:
SCHWARZ EM
KRIMPENFORT P
ROBANUSMAANDAG E
BERNS A
VERMA IM
Citation: Em. Schwarz et al., IMMUNOLOGICAL DEFECTS IN MICE WITH A TARGETED DISRUPTION IN BCL-3 (VOL 11, PG 187, 1997), Genes & development, 11(4), 1997, pp. 542-542
Authors:
SCHWARZ EM
KRIMPENFORT P
BERNS A
VERMA IM
Citation: Em. Schwarz et al., IMMUNOLOGICAL DEFECTS IN MICE WITH A TARGETED DISRUPTION IN BCL-3, Genes & development, 11(2), 1997, pp. 187-197
Authors:
VERMA IM
Citation: Im. Verma, HOT PAPERS - GENE-THERAPY - CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS FOR LONG-TERM EXPRESSION BY DAI,Y., SCHWARTZ,E.M., GU,D., ZHANG,W.W., SARVETNICK,N., VERMA,I.M. - COMMENTS, The Scientist, 11(4), 1997, pp. 16-16
Authors:
VERMA IM
SOMIA N
Citation: Im. Verma et N. Somia, GENE-THERAPY - PROMISES, PROBLEMS AND PROSPECTS, Nature, 389(6648), 1997, pp. 239-242
Authors:
VERMA IM
STEVENSON J
Citation: Im. Verma et J. Stevenson, I-KAPPA-B KINASE - BEGINNING, NOT THE END, Proceedings of the National Academy of Sciences of the United Statesof America, 94(22), 1997, pp. 11758-11760
Authors:
WANG LL
ZOPPE M
HACKENG TM
GRIFFIN JH
LEE KF
VERMA IM
Citation: Ll. Wang et al., A FACTOR IX-DEFICIENT MOUSE MODEL FOR HEMOPHILIA-B GENE-THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(21), 1997, pp. 11563-11566
Authors:
MIYOSHI H
TAKAHASHI M
GAGE FH
VERMA IM
Citation: H. Miyoshi et al., STABLE AND EFFICIENT GENE-TRANSFER INTO THE RETINA USING AN HIV-BASEDLENTIVIRAL VECTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 94(19), 1997, pp. 10319-10323
Authors:
TASHIRO K
PANDO MP
KANEGAE Y
WAMSLEY PM
INOUE S
VERMA IM
Citation: K. Tashiro et al., DIRECT INVOLVEMENT OF THE UBIQUITIN-CONJUGATING ENZYME UBC9 HUS5 IN THE DEGRADATION OF I-KAPPA-B-ALPHA/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(15), 1997, pp. 7862-7867
Authors:
RUFFNER H
VERMA IM
Citation: H. Ruffner et Im. Verma, BRCA1 IS A CELL-CYCLE-REGULATED NUCLEAR PHOSPHOPROTEIN, Proceedings of the National Academy of Sciences of the United Statesof America, 94(14), 1997, pp. 7138-7143
Authors:
BLOMER U
NALDINI L
KAFRI T
TRONO D
VERMA IM
GAGE FH
Citation: U. Blomer et al., HIGHLY EFFICIENT AND SUSTAINED GENE-TRANSFER IN ADULT NEURONS WITH A LENTIVIRUS VECTOR, Journal of virology, 71(9), 1997, pp. 6641-6649
Authors:
WANG L
ZOPPE M
HACKENG TM
GRIFFIN JH
LEE KF
VERMA IM
Citation: L. Wang et al., A FACTOR IX-DEFICIENT MOUSE MODEL FOR HEMOPHILIA-B GENE-THERAPY, Blood, 90(10), 1997, pp. 2530-2530
Authors:
VERMA IM
Citation: Im. Verma, GREEN LIGHT FOR GENE-TRANSFER, Nature biotechnology, 14(5), 1996, pp. 576-576
Authors:
BLOMER U
NALDINI L
VERMA IM
TRONO D
GAGE FH
Citation: U. Blomer et al., APPLICATIONS OF GENE-THERAPY TO THE CNS, Human molecular genetics, 5, 1996, pp. 1397-1404
Authors:
VERMA IM
Citation: Im. Verma, GENE-THERAPY - POTENTIAL, PITFALLS AND PROSPECTS, Journal of clinical biochemistry and nutrition, 21(1), 1996, pp. 67-68